Drug development investors
6 investors that name Drug development among their sectors are recorded here: 2 corporate venture arms, 2 venture capital firms, 1 family office and 1 undefined. Stated investment stages run from pre-seed to growth. Most are headquartered in the United States (3), Switzerland (1) and Israel (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| AION Labs AI · pharma · drug discovery · drug development |
Direct investor | Venture studio | Pre-seed – Seed | Rehovot, Israel |
| Astellas Venture Management biotechnology · therapeutics · platform technologies · drug discovery |
Direct investor | Corporate venture | Pre-seed – Series A | South San Francisco, United States |
| Flerie Invest biotech · pharmaceutical · drug development · related devices |
Direct + LP | Family office | Pre-seed – Growth | Stockholm, Sweden |
| Longevity Funds 2 LLC longevity · biotech · drug development |
Direct investor | Venture capital | Seed – Series C+ | San Francisco, United States |
| MPM BioImpact biotechnology · drug development · oncology · immunology |
Direct + LP | Venture capital | Seed – Growth | Boston, United States |
| Novartis Venture Fund biotechnology · biopharmaceuticals · life sciences · healthcare |
Direct investor | Corporate venture | Seed – Growth | Basel, Switzerland |